Watchlist Price Alert

Acrivon Therapeutics Inc.... (ACRV)

NASDAQ: ACRV · Real-Time Price · USD

1.21

-0.01 (-0.82%)

At close: Jun 17, 2025, 3:59 PM

1.23

2.07%

Pre-market: Jun 18, 2025, 07:27 AM EDT

Acrivon Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Net Income	-19.68M	-22.83M	-22.44M	-18.8M	-16.49M	-19.25M	-14.47M	-13.91M	-12.76M	-8.93M	-9.2M	-5.82M	-7.22M	-4.34M	-2.44M
Depreciation & Amortization	-49K	303K	251K	200K	224K	149K	133K	129K	125K	125K	116K	78K	45K	13K	9K
Stock-Based Compensation	3.79M	3.71M	3.67M	3.57M	3.34M	3.06M	3.23M	2.69M	2.65M	1.65M	267K	233K	40K	304K	27K
Other Working Capital	n/a	2.35M	1.98M	2.91M	-1.54M	995K	1.77M	2.67M	-470K	-1.14M	2.26M	-1.04M	-1.37M	-163K	-278K
Other Non-Cash Items	n/a	-654K	-968K	-870K	5.71M	-300K	198K	195K	-942K	-328K	2K	181K	178K	258K	18K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	-186K	-742K	-768K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	2.12M	2.16M	1.97M	-3.81M	4.17M	1.84M	2.56M	-430K	-1.87M	2.29M	-496K	-1.46M	141K	72K
Operating Cash Flow	-19.54M	-17.36M	-17.32M	-13.9M	-17.08M	-12.37M	-9.81M	-9.11M	-11.36M	-9.35M	-6.52M	-5.82M	-8.42M	-3.63M	-2.31M
Capital Expenditures	-58K	-827K	-989K	-137K	-815K	-1.15M	n/a	-112K	-25K	-251K	-426K	-1.07M	-415K	-137K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-44.69M	44.69M	n/a	n/a	n/a	n/a
Purchase of Investments	-20.23M	-34.76M	-5M	-134.83M	-28.34M	-16.58M	-22.98M	n/a	-16.96M	-100.81M	-49.37M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	39.5M	50M	22M	46.92M	35M	38.27M	24.5M	19.45M	26.32M	6M	4.67M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	44.69M	-44.69M	n/a	n/a	n/a	n/a
Investing Cash Flow	19.21M	14.41M	16.01M	-88.04M	5.85M	20.54M	1.52M	19.34M	9.33M	-95.07M	-45.12M	-1.07M	-415K	-137K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-343K	-647K	-1.2M	-510K	-166K	-1.3M	n/a	n/a	n/a	101.86M	11K	-11K	n/a	n/a	1K
Financial Cash Flow	-343K	-647K	-1.5M	123.35M	-172K	-2.01M	78K	379K	n/a	101.86M	-140K	-11K	n/a	99.75M	1K
Net Cash Flow	-664K	-3.6M	-2.4M	21.4M	-11.41M	6.16M	-8.21M	10.61M	-2.03M	-2.56M	-51.78M	-6.91M	-8.83M	95.99M	-2.31M
Free Cash Flow	-19.59M	-18.19M	-18.31M	-14.04M	-17.9M	-13.52M	-9.81M	-9.22M	-11.38M	-9.61M	-6.95M	-6.9M	-8.83M	-3.76M	-2.31M